tyrosine has been researched along with Cognition Disorders in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (7.14) | 18.7374 |
| 1990's | 2 (7.14) | 18.2507 |
| 2000's | 8 (28.57) | 29.6817 |
| 2010's | 16 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuchs, D; Geisler, S; Leblhuber, F; Wissmann, P | 1 |
| Brewer, LD; Butterfield, DA; Cai, J; Förster, S; Keeney, JTR; Klein, JB; Latimer, CS; Porter, NM; Sultana, R | 1 |
| Soloway, AH; Soloway, PD; Warner, VD | 1 |
| Colzato, LS; Hommel, B; Jongkees, BJ; Kühn, S | 1 |
| Jiang-Hui, G; Ning, J; Qiong, W; Shan-Guang, C; Xin-Min, L; Yi-Xi, C; Ying-Hui, L; Yong-Liang, Z | 1 |
| Davis, MJ; Doctrow, SR; Moulder, JE; Pfankuch, T; Raber, J; Rosenthal, R | 1 |
| Fu, J; Liu, X; Liu, Z; Ran, J; Shi, Q; Wang, N; Zheng, J; Zheng, X | 1 |
| Alkam, T; Itoh, A; Mizoguchi, H; Murai, R; Nabeshima, T; Nagai, T; Nitta, A; Yamada, K | 1 |
| Adamo, G; Coppola, A; Coppola, L; Gombos, I; Luongo, M; Manzella, D; Mastrolorenzo, L; Pastore, A | 1 |
| McGill, J; Sharman, R; Sullivan, K; Young, R | 1 |
| Benkelfat, C; Coderre, E; Dumas, J; Naylor, M; Newhouse, PA; Sites, CK; Wilkins, H; Young, SN | 1 |
| Borg, K; Edman, G; Flyckt, L; Venizelos, N | 1 |
| Kaundal, RK; Sharma, SS | 1 |
| Carton, D; Dan, B; De Laet, C; François, B; Goyens, PJ; Jaeken, J; Munoz, VT; Sokal, EM | 1 |
| Bruno, MA; Cuello, AC | 1 |
| Herebian, D; Kamp, G; Klee, D; Mayatepek, E; Molke, B; Richter-Werkle, R; Spiekerkoetter, U; Thimm, E | 1 |
| Biernacka, M; Biernacki, M; Jakubowska-Winecka, A; Kowalik, A; Kuśmierska, K; Pohorecka, M; Sykut-Cegielska, J | 1 |
| Aoyama, K; Chen, Y; Garnier, P; Gum, E; Liu, J; Matsumori, Y; Suh, SW; Swanson, RA | 1 |
| Ahmed, N; Ahmed, U; Fleischer, G; Hager, K; Münch, G; Thornalley, PJ | 1 |
| Bamber, DJ; Blackwell, AD; Goodyer, I; Jones, PB; McLean, A; Ogilvie, AD; Roiser, JP; Sahakian, BJ | 1 |
| Bjerkenstedt, L; Edman, G; Eriksson, A; Flyckt, L; Nyman, H; Venizelos, N; Wiesel, FA | 1 |
| Ellis, KA; Grasby, PM; McTavish, SF; Mehta, MA; Naga Venkatesha Murthy, PJ; Nathan, PJ | 1 |
| Butterfield, DA; Coccia, R; De Marco, C; Keller, JN; Markesbery, WR; Perluigi, M; Reed, TT; Sultana, R | 1 |
| Butterfield, DA; Cenini, G; Memo, M; Sultana, R | 1 |
| de Sonneville, L; Kutscha, A; Landwehr, R; Pietz, J; Schmidt, H; Trefz, FK | 1 |
| Callender, G; Diamond, A; Druin, DP; Prevor, MB | 1 |
| Banderet, LE; Lieberman, HR | 1 |
| Ruge, W | 1 |
1 review(s) available for tyrosine and Cognition Disorders
| Article | Year |
|---|---|
Effect of tyrosine supplementation on clinical and healthy populations under stress or cognitive demands--A review.
Topics: Animals; Cognition; Cognition Disorders; Dietary Supplements; Humans; Stress, Psychological; Tyrosine | 2015 |
5 trial(s) available for tyrosine and Cognition Disorders
| Article | Year |
|---|---|
Estrogen treatment impairs cognitive performance after psychosocial stress and monoamine depletion in postmenopausal women.
Topics: Affect; Aged; Aged, 80 and over; Anxiety; Cognition Disorders; Double-Blind Method; Estradiol; Estrogens; Female; Follicle Stimulating Hormone; Humans; Hydrocortisone; Mental Recall; Middle Aged; Neuropsychological Tests; Phenylalanine; Postmenopause; Stress, Psychological; Tryptophan; Tyrosine | 2010 |
Neuropsychological outcome of NTBC-treated patients with tyrosinaemia type 1.
Topics: Adolescent; Belgium; Child; Child, Preschool; Cognition Disorders; Cyclohexanones; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Intelligence; Intelligence Tests; Male; Neuropsychological Tests; Nitrobenzoates; Phenylalanine; Treatment Outcome; Tyrosine; Tyrosinemias | 2011 |
The subjective and cognitive effects of acute phenylalanine and tyrosine depletion in patients recovered from depression.
Topics: Adult; Amino Acids, Neutral; Brain; Cognition Disorders; Cross-Over Studies; Decision Making; Depressive Disorder; Dopamine; Double-Blind Method; Female; Food, Formulated; Gambling; Humans; Judgment; Male; Middle Aged; Neuropsychological Tests; Phenylalanine; Recovery of Function; Reward; Tyrosine | 2005 |
Effect of high-dose tyrosine supplementation on brain function in adults with phenylketonuria.
Topics: Adolescent; Adult; Brain; Cognition Disorders; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electroencephalography; Evoked Potentials, Visual; Female; Humans; Male; Neuropsychological Tests; Phenylalanine; Phenylketonurias; Placebos; Psychological Tests; Reaction Time; Tyrosine | 1995 |
Treatment with tyrosine, a neurotransmitter precursor, reduces environmental stress in humans.
Topics: Adolescent; Adult; Cognition Disorders; Cold Temperature; Double-Blind Method; Humans; Hypoxia; Male; Stress, Physiological; Tyrosine | 1989 |
22 other study(ies) available for tyrosine and Cognition Disorders
| Article | Year |
|---|---|
Immune activation in patients with Alzheimer's disease is associated with high serum phenylalanine concentrations.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognition Disorders; Enzyme-Linked Immunosorbent Assay; Female; Humans; Kynurenine; Male; Middle Aged; Neopterin; Neuropsychological Tests; Phenylalanine; Psychiatric Status Rating Scales; Single-Blind Method; Statistics, Nonparametric; Tyrosine | 2013 |
Dietary vitamin D deficiency in rats from middle to old age leads to elevated tyrosine nitration and proteomics changes in levels of key proteins in brain: implications for low vitamin D-dependent age-related cognitive decline.
Topics: Aging; Animals; Blotting, Western; Brain; Cognition Disorders; Diet; Disease Models, Animal; Isoelectric Focusing; Male; Mass Spectrometry; Nitrosation; Proteomics; Rats; Rats, Inbred F344; Tyrosine; Vitamin D Deficiency | 2013 |
Possible chemical initiators of cognitive dysfunction in phenylketonuria, Parkinson's disease and Alzheimer's disease.
Topics: Alzheimer Disease; Catechols; Cognition Disorders; Humans; Metabolic Networks and Pathways; Methionine; Models, Biological; Molecular Structure; Oxidative Stress; Parkinson Disease; Phenylalanine; Phenylketonurias; Tyrosine | 2013 |
The memory enhancement effect of Kai Xin San on cognitive deficit induced by simulated weightlessness in rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Acetylcholinesterase; Animals; Avoidance Learning; Brain; Choline O-Acetyltransferase; Cognition Disorders; Deoxyguanosine; Disease Models, Animal; Drugs, Chinese Herbal; Escape Reaction; Hindlimb Suspension; Male; Memory; Neuroprotective Agents; Phytotherapy; Rats, Sprague-Dawley; Reactive Oxygen Species; Swimming; Tyrosine; Weightlessness | 2016 |
Mitigating effect of EUK-207 on radiation-induced cognitive impairments.
Topics: Analysis of Variance; Animals; Cognition Disorders; Conditioning, Psychological; Dose-Response Relationship, Radiation; Fear; Male; Maze Learning; Mice; Mice, Inbred C57BL; Organometallic Compounds; Radiation Injuries, Experimental; Superoxide Dismutase; Tyrosine | 2017 |
1400W ameliorates acute hypobaric hypoxia/reoxygenation-induced cognitive deficits by suppressing the induction of inducible nitric oxide synthase in rat cerebral cortex microglia.
Topics: Animals; Annexin A5; Apoptosis; Cells, Cultured; Cognition Disorders; Disease Models, Animal; Gene Expression Regulation; Hypoxia; Imines; Lipid Peroxidation; Malondialdehyde; Maze Learning; Microglia; Nerve Tissue Proteins; Nitric Oxide; Nitric Oxide Synthase Type II; Oxygen; Rats; Rats, Sprague-Dawley; Tyrosine | 2017 |
The extensive nitration of neurofilament light chain in the hippocampus is associated with the cognitive impairment induced by amyloid beta in mice.
Topics: Amyloid beta-Peptides; Animals; Cognition Disorders; Cytoskeleton; Hippocampus; Male; Mice; Mice, Inbred ICR; Neurofilament Proteins; Nitrates; Phosphorylation; Serine; Tyrosine | 2008 |
Circulating free nitrotyrosine and cognitive decline.
Topics: Adult; Aged; Aged, 80 and over; Blood Cell Count; Body Weight; Cognition Disorders; Enzyme-Linked Immunosorbent Assay; Female; Hemoglobins; Humans; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Residence Characteristics; Sex Factors; Tyrosine | 2010 |
A preliminary investigation of the role of the phenylalanine:tyrosine ratio in children with early and continuously treated phenylketonuria: toward identification of "safe" levels.
Topics: Adolescent; Analysis of Variance; Child; Cognition Disorders; Executive Function; Humans; Neuropsychological Tests; Phenylalanine; Phenylketonurias; Severity of Illness Index; Surveys and Questionnaires; Tyrosine | 2010 |
Aberrant tyrosine transport across the fibroblast membrane in patients with schizophrenia--indications of maternal inheritance.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Cell Membrane; Cells, Cultured; Cognition Disorders; Family Health; Female; Fibroblasts; Humans; Male; Middle Aged; Neuropsychological Tests; Parents; Schizophrenia; Skin; Tyrosine; Young Adult | 2011 |
GW1929: a nonthiazolidinedione PPARγ agonist, ameliorates neurological damage in global cerebral ischemic-reperfusion injury through reduction in inflammation and DNA fragmentation.
Topics: Analysis of Variance; Animals; Benzophenones; Brain Damage, Chronic; Brain Ischemia; Cognition Disorders; DNA Fragmentation; Gerbillinae; Hippocampus; Male; Motor Activity; Neuroprotective Agents; PPAR gamma; Reperfusion Injury; Tyrosine | 2011 |
Cortical peroxynitration of nerve growth factor in aged and cognitively impaired rats.
Topics: Age Factors; Aging; Animals; Cerebral Cortex; Choline O-Acetyltransferase; Cognition Disorders; Immunoprecipitation; Male; Maze Learning; Nerve Growth Factor; Nerve Growth Factors; Plasminogen; Protein Precursors; Rats; Rats, Inbred F344; Reaction Time; Tissue Plasminogen Activator; Tyrosine | 2012 |
Neurocognitive outcome in patients with hypertyrosinemia type I after long-term treatment with NTBC.
Topics: Cerebrum; Child; Child, Preschool; Cognition; Cognition Disorders; Cyclohexanones; Enzyme Inhibitors; Female; Humans; Infant; Language Development; Long-Term Care; Male; Motor Activity; Nitrobenzoates; Psychometrics; Time; Treatment Outcome; Tyrosine; Tyrosinemias | 2012 |
Behavioral and intellectual functioning in patients with tyrosinemia type I.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Cognition Disorders; Female; Humans; Intelligence Tests; Male; Mental Disorders; Phenylalanine; Problem Solving; Tyrosine; Tyrosinemias; Wechsler Scales | 2012 |
Hypoglycemic neuronal death and cognitive impairment are prevented by poly(ADP-ribose) polymerase inhibitors administered after hypoglycemia.
Topics: Animals; Astrocytes; Behavior, Animal; Benzamides; Benzopyrans; Cell Death; Cells, Cultured; Cognition Disorders; Disease Models, Animal; Drug Administration Schedule; Enzyme Inhibitors; Hypoglycemia; Isoquinolines; Male; Maze Learning; Mice; Mice, Knockout; Neurons; Poly(ADP-ribose) Polymerase Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Time Factors; Treatment Outcome; Tyrosine | 2003 |
Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment.
Topics: Aged; Alzheimer Disease; Biomarkers; Cerebrospinal Fluid Proteins; Cognition Disorders; Female; Glycosylation; Humans; Lysine; Male; Neuropsychological Tests; Nitrates; Nitroso Compounds; Oxidation-Reduction; Reference Values; Tyrosine | 2005 |
Kinetics of tyrosine transport and cognitive functioning in schizophrenia.
Topics: Adolescent; Adult; Biological Transport; Biopsy; Brain; Cognition Disorders; Diagnostic and Statistical Manual of Mental Disorders; Female; Fibroblasts; Humans; Male; Middle Aged; Schizophrenia; Skin; Tyrosine | 2005 |
Tyrosine depletion alters cortical and limbic blood flow but does not modulate spatial working memory performance or task-related blood flow in humans.
Topics: Adult; Amino Acids; Brain Mapping; Cerebral Cortex; Cerebrovascular Circulation; Cognition; Cognition Disorders; Dopamine; Food, Formulated; Functional Laterality; Humans; Image Processing, Computer-Assisted; Limbic System; Male; Memory Disorders; Memory, Short-Term; Middle Aged; Nerve Net; Neuropsychological Tests; Positron-Emission Tomography; Psychomotor Performance; Tyrosine | 2007 |
Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease.
Topics: Aged, 80 and over; Alzheimer Disease; Amnesia; Biomarkers; Brain; Cognition Disorders; Disease Progression; Early Diagnosis; Female; Hippocampus; Humans; Immunohistochemistry; Male; Nerve Tissue Proteins; Nitrates; Oxidative Stress; Parietal Lobe; Predictive Value of Tests; Prognosis; Tyrosine; Up-Regulation | 2007 |
Effects of oxidative and nitrosative stress in brain on p53 proapoptotic protein in amnestic mild cognitive impairment and Alzheimer disease.
Topics: Aged, 80 and over; Alzheimer Disease; Amnesia; Apoptosis; Brain; Cognition Disorders; Female; Humans; Male; Nitrogen; Oxidation-Reduction; Oxidative Stress; Protein Binding; Tumor Suppressor Protein p53; Tyrosine | 2008 |
Prefrontal cortex cognitive deficits in children treated early and continuously for PKU.
Topics: Age Factors; Analysis of Variance; Attention; Case-Control Studies; Child; Child, Preschool; Cognition Disorders; Cross-Sectional Studies; Female; Humans; Infant; Inhibition, Psychological; Intelligence; Longitudinal Studies; Male; Memory; Neuropsychological Tests; Phenylalanine; Phenylketonurias; Prefrontal Cortex; Regression Analysis; Sex Factors; Tyrosine; Volition | 1997 |
[Metabolic disorders and encephalopathy. Studies on phenolic compounds in consciousness disorders following liver diseases].
Topics: Amino Acids; Blood-Brain Barrier; Brain Diseases; Cognition Disorders; Female; Hepatic Encephalopathy; Humans; Liver Diseases; Male; Metabolic Diseases; Middle Aged; Phenols; Tyrosine; Uremia | 1972 |